Publication | Closed Access
Use of the Monoclonal Antibody Anti-HER2 Trastuzumab in the Treatment of Metastatic Breast Cancer
27
Citations
11
References
2008
Year
The related additional cost seems affordable for an European health care system and justifies the recommendation for its use in the subpopulation overexpressing HER2.
| Year | Citations | |
|---|---|---|
Page 1
Page 1